CDCA5 and neoplasm: Upon subcutaneous implantation, HCT116 xenograft transduced with sh-CDCA5 grew at a much lower rate vs. the control (Fig. 6a for tumor volume; Fig. 6b for intratumoral green fluorescent protein (GFP) fluorescence and Fig. 6c for tumor weight; P < 0.05 for all).